A carregar...
Genetic and Epigenetic Heterogeneity and the Impact on Cancer Relapse
Acute myeloid leukemia (AML) is an aggressive hematopoietic malignancy with an exceedingly poor prognosis, showing a 5-year overall survival rate of 40–45% in the young and a 5-year survival rate of below 10% in the elderly (>60y). Though a high percentage of patients enter complete remission fol...
Na minha lista:
| Publicado no: | Exp Hematol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5651672/ https://ncbi.nlm.nih.gov/pubmed/28705639 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2017.07.002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|